While access remains uneven across commercial plans and Medicare coverage for obesity medicines is still limited, CVS decision signals continued normalization of GLP-1 therapies within mainstream pharmacy benefit design and intensifies competition between Lilly and Novo Nordisk for long-term market leadership in obesity careTop of FormBottom of Form Sources CVS brings back coverage for Lilly's obesity drug Zepbound Reuters May 28, 2026 Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge Reuters May 1, 2025
Gilead gains Hepcludex (bulevirtide), which was conditionally approved by the European Medicines Agency for the treatment of chronic HDV infection in adults with compensated liver disease in July 2020
Details Product Information About brand: 9wishes Korean beauty brand 9wishes takes its name from the auspicious number 9, which alludes to perfection in Korean culture
Surgical procedures include excision, fulguration, or laser ablation of endometriotic implants on the peritoneum, excision or drainage or ablation of endometriomas, resection of rectovaginal nodules, lysis of adhesions, and interruption of nerve pathways
Among adolescents, the researchers noted that the number who were dispensed exenatide, liraglutide or dulaglutide was greatest throughout the study period and increased steadily, whereas the number who were dispensed injectable semaglutide for weight management increased in 2023